Sort   by:  
 Page size 
Unknown5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer.
Not available
S-EPMC5893252 | biostudies-literature
UnknownDisease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.
Not available
S-EPMC9315975 | biostudies-literature
UnknownData monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Not available
S-EPMC10264214 | biostudies-literature
UnknownThe Italian multiple sclerosis register.
Not available
S-EPMC6329744 | biostudies-literature
UnknownComparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Not available
S-EPMC10186210 | biostudies-literature
UnknownDo patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
Not available
S-EPMC9385759 | biostudies-literature
Sort   by:  
 Page size